Owlstone Medical Stock

owlstonemedical.comHealthcareFounded: 2003

Owlstone Medical is developing a breathalyzer for the early detection of cancer and other inflammatory and infectious diseases. The company's mission is to save 100,000 lives and $1.5B in healthcare costs. Utilizing breath-based diagnostics through the development and application of Breath Biopsy®, Owlstone Medical provides high value Breath Biopsy® products and services to pharmaceutical and academic clients including Cleveland Clinic, AstraZeneca, Actelion Pharmaceuticals (a J&J company), and GSK, where the company supports their biomarker discovery or disease research projects.

Register for Details

For more details on financing and valuation for Owlstone Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Owlstone Medical.

Register Today

Owlstone Medical investors also invested in these private companies


Management Team

Billy Boyle
Chief Executive Officer
Martin Nash
Head of Product Management
John Boyle
Head of Information Science
Pam Lauder
Head of Finance

Other companies like Owlstone Medical in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation